Literature DB >> 30517006

CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels.

Kang Xiao1, Jie Gao1, Shi-Jia Weng1, Yan Fang1, Na Gao1, Qiang Wen1, Han Jin1, Hai-Ling Qiao1.   

Abstract

Testosterone (TST) and midazolam (MDZ) are widely used as probes to detect CYP3A4/5 activity, but the data acquired with these two substrates do not correlate well at the microsomal level (per milligram of microsomal protein), and the reason is unclear. In this study, CYP3A4/5 activity was probed with TST and MDZ at the microsomal and enzyme levels (per picomole of CYP3A4/5) in 72 human liver samples. Correlation coefficients were lower in Vmax and CLint at the microsomal level, as compared with those at the enzyme level ( Vmax 0.658 vs 0.883; CLint no correlation vs 0.796). Compared with TST, MDZ was found to correlate better with the content of CYP3A4/5 (no correlation vs 0.431) and CYP3A5 (no correlation vs 0.447), and huge variations in enzyme content existed among different genotypes, which explained the lower degree of correlation at the microsomal level. In addition, different genotypes had varying effects on activity at the enzyme level, whereas the difference between activity at the enzyme level probed with TST and that probed with MDZ was not obvious ( P > 0.05), indicating that the effect of gene polymorphisms on correlation between activity probed with these two substrates was limited at the enzyme level. In conclusion, our study demonstrates a high degree of correlation between CYP3A4/5 activity probed with TST and MDZ at the enzyme level but not at the microsomal level and allows us to correctly understand the influence of gene polymorphisms on the correlations.

Entities:  

Keywords:  CYP3A4/5 activity; correlation; midazolam; testosterone

Mesh:

Substances:

Year:  2018        PMID: 30517006     DOI: 10.1021/acs.molpharmaceut.8b01043

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  3 in total

1.  Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5.

Authors:  William C Wright; Jude Chenge; Jingheng Wang; Hazel M Girvan; Lei Yang; Sergio C Chai; Andrew D Huber; Jing Wu; Peter O Oladimeji; Andrew W Munro; Taosheng Chen
Journal:  J Med Chem       Date:  2020-01-22       Impact factor: 7.446

2.  Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.

Authors:  Shinpei Yoshida; Takayuki Honjo; Keita Iino; Ryunosuke Ishibe; Sylvia Leo; Tomoka Shimada; Teruhiko Watanabe; Masaya Ishikawa; Kazuya Maeda; Hiroyuki Kusuhara; Nobuaki Shiraki; Shoen Kume
Journal:  Stem Cell Reports       Date:  2021-01-28       Impact factor: 7.765

3.  Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker.

Authors:  Miao Zhang; Zhiheng Yu; Xueting Yao; Zihan Lei; Kaijing Zhao; Wenqian Wang; Xue Zhang; Xijing Chen; Dongyang Liu
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.